Unlocking New Pathways for Chinese MedTech and Pharma Global Expansion: Insights from the 2026 Forum

From “Made in China” to “Created in China,” China’s pharmaceutical and medical device industry stands at a critical juncture of globalization.

Medical device exports have shown particularly strong performance. According to data from the China Chamber of Commerce for Import and Export of Medicines and Health Products, the total export value for the year reached $50.469 billion, a year-on-year increase of 3.54%. Among these, IVD instrument exports grew by 36.1%, while CT scanners and endoscopes exported to North America achieved a compound annual growth rate exceeding 30%. High-end equipment such as surgical robots saw significant growth in the EU market. Domestically produced innovative medical devices are accelerating their entry into mainstream markets including Europe, the United States, Southeast Asia, and the Middle East.

The innovative drug sector is also seeing a stream of good news. Gan&Lee Pharmaceuticals has secured a 10-year contract worth RMB 3 billion in Brazil, while Innovent Bio has reached a multi-billion-dollar partnership with Takeda, marking the continued implementation of global strategies by Chinese pharmaceutical companies.

However, on the other hand, regulatory upgrades under the EU MDR/IVDR, stricter FDA approval processes in the United States, high international clinical trial costs, and frequent intellectual property disputes pose significant challenges. Behind the impressive achievements lie obstacles that companies must directly confront, making these critical issues to be resolved for Chinese pharmaceutical and medical device enterprises expanding into global markets.

Through in-depth exchanges with a large number of enterprises expanding overseas, we have found that their predicaments often stem not from insufficient product competitiveness, but from a lack of strategy, tools, and channels at critical junctures:

Information Level: Understanding of the target market remains limited to fragmented information.

Southeast Asia is heating up, but what are the differences in market access pathways between Indonesia and Thailand?

Middle East in the Spotlight: Whose Procurement Logic Is Clearer, Saudi Arabia or the UAE?

The European Market Is Huge, but How Much Time Is Left in the Transition Period Under the New MDR Regulations?

Resource Level, how to find reliable partners? How to connect with suitable local channels?

Strategic ApproachHow to Spend the Budget Where It Matters Most? Build an In-House Team or Engage an Agency?

Behind these dilemmas lies the urgent expectation of Chinese enterprises for a platform that can “truly help.”

And this is precisely what VCBeat has been consistently doing over the past few years.

As an in-depth observer of China’s healthcare industry, VCBeat continuously tracks the global expansion needs of domestic companies through its enterprise demand database, and connects key global resources—including distributors, CROs, law firms, and experts—via its overseas service provider resource pool, thereby building a bridge of trust between China and the rest of the world.

Currently, VCBeat has established a global network spanning over 30 countries across Europe, Southeast Asia, North America, Latin America, and Africa, connecting with national embassies and consulates, investment promotion agencies, and industry associations. This network precisely links key resources across various critical stages, including overseas sales channels, market access, regulations and intellectual property, talent and fiscal/tax services, as well as logistics, warehousing, and supply chain management.

We are committed to creating a professional platform for open dialogue, bringing together China’s innovative forces, international buyers, and overseas enablers to directly address pain points and facilitate in-depth matchmaking—this is the original intention of this forum.

2026 Future Healthcare & Pharmaceutical Top 100 Conference — Forum on International Market Expansion for Pharmaceuticals and Medical Devices, will officially open in Shanghai on May 19, 2026.

Not a superficial trend analysis, nor a one-way industry presentation, but ratherAn Industry Gathering for Genuine Dialogue and Precise Matching Between Supply and Demand。

Proposed Agenda for the Forum

"First Lesson in the Global Market" Makes Its Debut.We will invite practical experts or regulatory officials with deep expertise in a single target market—such as Southeast Asia, Japan and South Korea, the Middle East, Russia, or Central Asia—to provide an in-depth analysis of that market, covering policy and regulations, category demand, and the competitive landscape. In 20 minutes, you will gain clarity on the “actual rules beyond written policies,” empowering your enterprise with actionable insights for its global expansion.

Sharing Practical Cases of Global Expansion.We will invite seasoned experts who have achieved substantial breakthroughs in overseas markets to share their real-world global expansion experiences—from strategy and capital investment to pitfalls encountered and solutions for breaking through barriers. No empty talk, only actionable insights.

Product-driven enterprises expanding overseas, solution-providing service agencies, and investors seeking targets can all find their answers and connections here.

Forum Content, Decided by You! Make the Forum Truly "Quench Your Thirst"!

You are cordially invited to participate in [Pharmaceuticals and Medical Devices Going Global—Call for Topics: The First Lesson on the Global Market].

Which market are you most interested in? What resources do you most want to connect with? What insights do you most want to hear shared?

Your response will directly determine the topic selection for “The First Lesson on the Global Market” and the direction of the “Annual Topic Roundtable.”

[First Lesson on the Global Market] Submission Portal

Return on Participation:

● All topic contributors will receive one complimentary ticket to the Pharmaceutical and Medical Device International Market Expansion Forum at the 2026 Top 100 Future Healthcare and Medicine Conference.

● Top contributors will receive one opportunity to post supply and demand information on the VCBeat platform (related to global expansion).

Conference Inquiries, Business Cooperation:

Ms. Wang 17774983530

Ms. Sun 15320258906